Ionis Pharmaceuticals, Inc.
MODULATORS OF MALAT1 EXPRESSION
Last updated:
Abstract:
The present embodiments provide methods, compounds, and compositions useful for inhibiting MALAT1 expression, which may be useful for treating, preventing, or ameliorating a cancer associated with MALAT1.
Status:
Application
Type:
Utility
Filling date:
8 Feb 2022
Issue date:
4 Aug 2022